BRCA1 promoter hypermethylation is an epigenetic change that silences expression of BRCA1 protein and is reported to drive an HRD phenotype in ovarian and breast cancers [17] but is not captured through DNA mutation calling [17]. The gene discussed is BRCA1; the disease is breast cancer.